Pilot Clinical Trial for Treatment of Diabetic Foot Ulcers with Dietary Nano-formulated Phytochemicals
Phase 2
- Conditions
- diabetic foot ulcersMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12610000565044
- Lead Sponsor
- CamMedica, Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Male
- Target Recruitment
- 35
Inclusion Criteria
Mediterranean and Middle Eastern males, age 18-65 (inclusive) suffering from Type 2 Diabetes with diabetic foot syndrome (1 and 2 grade Wagner scale) with body weight between 60-80 kg.
Stable metabolic and glycemic control during last three months of disease and during trial period.
Foot ulcer aged at least two weeks sized 0.5-2.0 cm.
Exclusion Criteria
Any foot ulceration not related to type 2 diabetes
Diabetic foot syndrome graded above 2 on Wagner's scale.
Kidney abnormalities requiring medical intervention.
Infectious complications of diabetic foot syndrome.
Critical abnormalities of blood circulation in affected limb.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method